Lung cancer

Lung cancer patients benefit from brachytherapy palliation

Endobronchial brachytherapy is underused for the palliation of symptoms in end-stage lung cancer despite its high response rate and low toxicity, NSW research suggests. According to a review of 95 procedures performed in 86 patients at St George Hospital, Sydney, between 1997 and 2016, the overall response rate was 73%. Patients with haemoptysis responded particularly ...

Already a member?

Login to keep reading.

© 2021 the limbic